Bailard »

Atea Pharmaceuticals shares owned by Bailard

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Bailard

Quarter filed Position value Share count Share price at filing
2026-06-30 $75k 16k 4.65
2021-12-31 $218k 24k 8.93

More positions owned by Bailard

Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard World Inf Tech Etf (VGT)
Ishares Tr Rus 2000 Val Etf (IWN)
Gilead Sciences (GILD)
Ishares Tr Core Msci Eafe (IEFA)
J P Morgan Exchange Traded F Mortgage Backed (JMTG)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Calif Mun Bd Etf (CMF)
Amazon (AMZN)

View all positions for Bailard

Top funds holding Atea Pharmaceuticals

FMR
BlackRock
BML Capital Management
Tang Capital Management
Vanguard Capital Management
Bain Capital Life Sciences Investors
Two Sigma Investments
Geode Capital Management
State Street Corporation
Acadian Asset Management
Dimensional Fund Advisors
Rosalind Advisors
Renaissance Technologies
Morgan Stanley
Curated Wealth Partners

View all funds holding Atea Pharmaceuticals